Guideline: Evidence-Based Best Practices for the Management of Cancer-Related Pain
The American Society of Pain and Neuroscience has published a best practice guideline for the management and reduction of cancer-associated pain.
Urology News
UROLOGY NEWS
Preoperative Blood Glucose Level Linked to Length of Stay After Nephrectomy for Renal Cell Carcinoma
Researchers found preoperative blood glucose levels were associated with hospital length of stay for patients undergoing laparoscopic nephrectomy for RCC.
Some Cancer Drugs Without Proven Benefit Still Recommended
Six of 18 indications remain on label for cancer drugs that failed to improve primary end point in trials after receiving accelerated approval
Abiraterone Added to ADT Improves Prostate Cancer Outcomes
Using abiraterone plus prednisolone with standard androgen deprivation therapy should be considered a new standard of care for patients with high-risk nonmetastatic prostate cancer, according to investigators.
First-Line Advanced RCC Combo Tx Improves Outcomes Regardless of Prior Surgery
As first-line therapy for advanced renal cell carcinoma, nivolumab plus cabozantinib prolongs progression-free survival compared with sunitinib in patients with and without a prior nephrectomy.
Prostate Cancer Risk Up for World Trade Center Rescue Workers
Risk most elevated for those to arrive earliest at the site, with a shorter latency period than the general population
Enzalutamide Shown to Slow Progression of Localized Prostate Cancer
A phase 2 exploratory study of men with low- and intermediate-risk localized prostate cancer demonstrated the oncologic benefit of enzalutamide treatment vs active surveillance.
RCC Subtype Affects Post-Nephrectomy Survival Rates
Five-year survival rates following nephrectomy for renal cell carcinoma are higher among patients with favorable vs unfavorable histology.
Plant-Based Diets Tied to Lower Risk for Aggressive Prostate Cancer
Greater consumption of healthful plant-based foods is associated with significantly reduced risks for advanced, lethal, and fatal prostate cancer, especially among men younger than 65 years.
Gender and Race Disparities Found in Kidney Stone Disease
A male-to-female gap decreased significantly over time among White and non-Hispanic stone formers, but not among Black stone formers.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...